Virgile Visentin Selected Research

Cannabinoids

1/2009

Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virgile Visentin Research Topics

Disease

1	Lung Neoplasms (Lung Cancer) 10/2021
1	Neoplasms (Cancer) 10/2021
1	Hypoxia (Hypoxemia) 10/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021
1	Atherosclerosis 01/2009
1	Weight Gain 01/2009
1	Body Weight (Weight, Body) 02/2007
1	Cachexia 02/2007
1	Wasting Syndrome (Wasting Disease) 02/2007
1	Insulin Resistance 12/2006
1	Hyperglycemia 10/2005
1	Obesity 03/2004
1	Morbid Obesity 03/2004

Drug/Important Bio-Agent (IBA)

1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 10/2021
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2009
1	RimonabantIBA 01/2009
1	LDL Receptors (LDL Receptor)IBA 01/2009
1	CannabinoidsIBA 01/2009
1	CholesterolIBA 01/2009
1	LipidsIBA 02/2007
1	Zn-Alpha-2-GlycoproteinIBA 02/2007
1	2-(2-benzofuranyl)-2-imidazolineIBA 12/2006
1	Glucose (Dextrose)FDA LinkGeneric 10/2005
1	TyramineIBA 10/2005
1	Monoamine Oxidase (MAO)IBA 03/2004
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2004
1	EnzymesIBA 03/2004

Therapy/Procedure

1	Therapeutics 10/2021